Dreyer Scott's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Feb 28, 2024
- Accession no.
- 0001062993-24-004754
- Filed
- Feb 28, 2024
- Trade date
- Feb 26, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $364.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dreyer ScottCIK 0001746251 | Officer (EVP & Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Common Stock | SSaleDisposed | −9,336 | $36.38 | −$339,643.68 | 139,582 | Direct | |
| Feb 26, 2024 | Common Stock | SSaleDisposed | −664 | $37.15 | −$24,667.6 | 138,918 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.